title: Indications and surgical treatment of chronic pancreatitis.
abstract: BACKGROUND
  Some patients with chronic pancreatitis (CP) may require surgery mainly because of intractable pain, suspicion of malignancy, or complications related to CP. This study aimed to analyze the efficacy of surgical treatment for patients with CP in terms of pain relief, control of local complications, and pancreatic endocrine/exocrine function.
  
  
  METHODS
  Twenty-six patients with CP were treated surgically at our hospital from June 1985 to November 2005. The clinical data of these patients were analyzed retrospectively.
  
  
  RESULTS
  The follow-up time ranged from 8 to 130 months with a median of 60.6 months. No patients were lost to follow-up. All patients had improvement of clinical symptoms such as abdominal pain, steatorrhea and weight loss, to some degree, especially pain relief in patients with good dilation and high pressure of the main pancreatic duct. The endocrine and exocrine functions were not alleviated in all patients, otherwise the impaired glucose tolerance was improved in 8 (30.8%), 15 (57.7%) maintained the same body weight, one (3.8%) had an acute attack of CP, and 2 (7.7%) developed pancreatic carcinoma in the 16th and 28th month postoperatively and died within 3 years after operation for CP. The 1-, 3-, 5-year pain-free rates of CP patients were 96.2% (25/26), 88.5% (23/26) and 84.6% (22/26), respectively.
  
  
  CONCLUSIONS
  In selected patients with CP, surgical treatment is a safe procedure and can effectively relieve pain and control local complications; also, it is helpful to improve the quality of life for patients with pancreatitis, and to control the development of this disease.
authors.affiliation: Department of General Surgery, First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China. slhan88@hotmail.com
authors.forename: Shao-Liang
authors.initials: SL
authors.lastname: Han
authors.forename: Jun
authors.initials: J
authors.lastname: Chen
authors.forename: Hong-Zhong
authors.initials: HZ
authors.lastname: Zhou
authors.forename: Sheng-Hong
authors.initials: SH
authors.lastname: Lan
authors.forename: Pei-Chen
authors.initials: PC
authors.lastname: Zhang
authors.forename: Guan-Bao
authors.initials: GB
authors.lastname: Zhu
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007515:Islets of Langerhans / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009017:Morbidity; D010146:Pain / Q000401:mortality / Q000601:surgery; D046790:Pancreas, Exocrine / Q000502:physiology; D010190:Pancreatic Neoplasms / Q000401:mortality; D016577:Pancreaticoduodenectomy / Q000401:mortality*; D010193:Pancreaticojejunostomy / Q000401:mortality*; D050500:Pancreatitis, Chronic / Q000401:mortality* / Q000601:surgery*; D011183:Postoperative Complications / Q000401:mortality*; D012189:Retrospective Studies